Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (876 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Case-Control Study; Studies, Case-Control; Study, Case-Control; Case-Comparison Studies; Case Comparison Studies; Case-Comparison Study; Studies, Case-Comparison; Study, Case-Comparison.
Where it fits in the MeSH classification
- Broader topics
- Epidemiologic Studies
- Narrower topics
- Retrospective Studies
Research landscape
PubMed indexes 1,759,224 records tagged with the MeSH heading “Case-Control Studies” (counts retrieved 2026-10-29). 666,050 of them (37.9%) were published from 2020 onward, and the busiest period so far is 2020 onward with 666,050 records.
Reviews account for 50,870 records (2.9%) and meta-analyses for 15,248. Randomized controlled trials number 15,189 (0.9%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.
Show the data
| Period | Records |
|---|---|
| through 1999 | 140,094 |
| 2000-2009 | 294,808 |
| 2010-2019 | 658,272 |
| 2020 onward | 666,050 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 50,870 | 2.9% |
| Meta-analyses | 15,248 | 0.9% |
| Randomized controlled trials | 15,189 | 0.9% |
Method: PubMed query "Case-Control Studies"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.
Reading the evidence in clinical research
Research methods determine how much a result can be trusted. Randomized trials guard against confounding, systematic reviews and meta-analyses combine many studies, and observational designs are valuable but can show only association. Reporting standards, trial registration and pre-specified outcomes reduce bias. When reading about a method, ask what problem it is designed to solve and which problems it does not solve.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology | 2005 | Research article Design not recorded in structured metadata | 111 | cc by PMID 16079783 · DOI · PMC2361558 |
| The effect of cold temperature on increased exacerbation of chronic obstructive pulmonary disease: a nationwide study | 2013 | Randomized controlled trial Design not recorded in structured metadata | 94 | cc by PMID 23554858 · DOI · PMC3598847 |
| The definition and measurement of heterogeneity | 2020 | Review article Design not recorded in structured metadata | 41 | cc by PMID 32839448 · DOI · PMC7445182 |
| Collapsibility in case-control studies | 2026 | Research article Design not recorded in structured metadata | 0 | cc by PMID 42217164 · DOI · PMC13221832 |
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology [1]
Abstract reading summary — source excerpts
- Opening excerpt
- Reproductive factors are associated with reduced risk of breast cancer, but less is known about whether there is differential protection against subtypes of breast cancer.
- Closing excerpt
- This study also suggests that reproductive factors have similar protective effects on breast tumours of lobular and ductal origin.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (258 words)
Reproductive factors are associated with reduced risk of breast cancer, but less is known about whether there is differential protection against subtypes of breast cancer. Assuming reproductive factors act through hormonal mechanisms they should protect predominantly against cancers expressing oestrogen (ER) and progesterone (PR) receptors. We examined the effect of reproductive factors on subgroups of tumours defined by hormone receptor status as well as histology using data from the NIHCD Women's Contraceptive and Reproductive Experiences (CARE) Study, a multicenter case-control study of breast cancer. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) as measures of relative risk using multivariate unconditional logistic regression methods. Multiparity and early age at first birth were associated with reduced relative risk of ER + PR + tumours (P for trend=0.0001 and 0.01, respectively), but not of ER - PR - tumours (P for trend=0.27 and 0.85), whereas duration of breastfeeding was associated with lower relative risk of both receptor-positive (P for trend=0.0002) and receptor-negative tumours (P=0.0004). Our results were consistent across subgroups of women based on age and ethnicity. We found few significant differences by histologic subtype, although the strongest protective effect of multiparity was seen for mixed ductolobular tumours. Our results indicate that parity and age at first birth are associated with reduced risk of receptor-positive tumours only, while lactation is associated with reduced risk of both receptor-positive and -negative tumours. This suggests that parity and lactation act through different mechanisms. This study also suggests that reproductive factors have similar protective effects on breast tumours of lobular and ductal origin.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 16079783 · DOI · PMC2361558
The effect of cold temperature on increased exacerbation of chronic obstructive pulmonary disease: a nationwide study [2]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundSeasonal variations in the acute exacerbation of chronic obstructive pulmonary disease (COPD) have been reported.
- Closing excerpt
- A more comprehensive program to prevent cold stress in COPD patients may lead to a reduction in the exacerbations rate of COPD.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (195 words)
BackgroundSeasonal variations in the acute exacerbation of chronic obstructive pulmonary disease (COPD) have been reported. However, the influence of air temperature and other meteorological factors on COPD exacerbation remains unclear.MethodsNational Health Insurance registry data from January 1, 1999 to December 1, 2009 and meteorological variables from the Taiwan Central Weather Bureau for the same period were analyzed. A case-crossover study design was used to investigate the association between COPD exacerbation and meteorological variables.ResultsA total of 16,254 cases who suffered from COPD exacerbation were enrolled. We found that a 1°C decrease in air temperature was associated with a 0.8% increase in the exacerbation rate on event-days (95% confidence interval (CI), 1.015-1.138, p = 0.015). With a 5°C decrease in mean temperature, the cold temperature (28-day average temperature) had a long-term effect on the exacerbation of COPD (odds ratio (OR), 1.106, 95% CI 1.063-1.152, pConclusionsThis study demonstrated the effect of cold temperatures on the COPD exacerbation rate. Elderly patients and those without inhaled medicine before the exacerbation event were affected significantly by lower mean temperatures. A more comprehensive program to prevent cold stress in COPD patients may lead to a reduction in the exacerbations rate of COPD.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 23554858 · DOI · PMC3598847
The definition and measurement of heterogeneity [3]
Abstract reading summary — source excerpts
- Opening excerpt
- Heterogeneity is an important concept in psychiatric research and science more broadly.
- Closing excerpt
- However, significant limitations must be overcome for these measures-largely developed for economic and ecological research-to be useful in modern translational psychiatric science.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (201 words)
Heterogeneity is an important concept in psychiatric research and science more broadly. It negatively impacts effect size estimates under case-control paradigms, and it exposes important flaws in our existing categorical nosology. Yet, our field has no precise definition of heterogeneity proper. We tend to quantify heterogeneity by measuring associated correlates such as entropy or variance: practices which are akin to accepting the radius of a sphere as a measure of its volume. Under a definition of heterogeneity as the degree to which a system deviates from perfect conformity, this paper argues that its proper measure roughly corresponds to the size of a system's event/sample space, and has units known as numbers equivalent. We arrive at this conclusion through focused review of more than 100 years of (re)discoveries of indices by ecologists, economists, statistical physicists, and others. In parallel, we review psychiatric approaches for quantifying heterogeneity, including but not limited to studies of symptom heterogeneity, microbiome biodiversity, cluster-counting, and time-series analyses. We argue that using numbers equivalent heterogeneity measures could improve the interpretability and synthesis of psychiatric research on heterogeneity. However, significant limitations must be overcome for these measures-largely developed for economic and ecological research-to be useful in modern translational psychiatric science.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32839448 · DOI · PMC7445182
Collapsibility in case-control studies [4]
Abstract reading summary — source excerpts
- Opening excerpt
- It is well-established that the odds ratio (OR) is non-collapsible and that adjustment of the OR for a risk factor can produce a change in the main effect estimate even when there is no confounding.
- Closing excerpt
- Moreover, if the disease under study is rare (in the cohort study), all three methods produce case-control ORs that are approximately collapsible.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (222 words)
It is well-established that the odds ratio (OR) is non-collapsible and that adjustment of the OR for a risk factor can produce a change in the main effect estimate even when there is no confounding. In contrast, the risk ratio (RR) is collapsible, whereas the rate ratio is non-collapsible, but usually to a lesser extent than is the case with ORs. However, almost all discussions of non-collapsibility have been conducted in the context of effect measures in cohort studies. In this paper, I consider non-collapsibility in case-control studies where the OR inherits the collapsibility or non-collapsibility of the ratio effect measure that the study was designed to estimate. This is most clearly illustrated in the situation of a closed cohort with a fixed follow-up time. In this situation, choosing controls by cumulative incidence sampling estimates the OR in the corresponding cohort study, and therefore the resulting case-control OR is non-collapsible. Choosing controls by case-cohort sampling estimates the cohort study RR, and the resulting case-control OR is collapsible. Choosing controls by density sampling (perhaps the most common approach) estimates the cohort study rate ratio, and the resulting case-control OR is non-collapsible, but to a lesser extent than for cumulative incidence sampling. Moreover, if the disease under study is rare (in the cohort study), all three methods produce case-control ORs that are approximately collapsible.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42217164 · DOI · PMC13221832
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Observational research methods. Research design II: cohort, cross sectional, and case-control studies [5]
- Research article Observational studies: cohort and case-control studies [6]
- Research article Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies [7]
- Research article Should we use a case-crossover design? [8]
- Research article Retrospective studies - utility and caveats [9]
- Research article Case-control and two-gate designs in diagnostic accuracy studies [10]
References
- Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, et al.. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. . 2005. PMID 16079783 · DOI · PMC2361558
- Tseng CM, Chen YT, Ou SM, Hsiao YH, Li SY, Wang SJ, et al.. The effect of cold temperature on increased exacerbation of chronic obstructive pulmonary disease: a nationwide study. . 2013. PMID 23554858 · DOI · PMC3598847
- Nunes A, Trappenberg T, Alda M. The definition and measurement of heterogeneity. . 2020. PMID 32839448 · DOI · PMC7445182
- Pearce N. Collapsibility in case-control studies. . 2026. PMID 42217164 · DOI · PMC13221832
- Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003. PMID 12533370 · DOI · PMC1726024
- Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010. PMID 20697313 · DOI · PMC2998589
- Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004. PMID 15286014 · DOI
- Maclure M, Mittleman MA. Should we use a case-crossover design?. Annu Rev Public Health. 2000. PMID 10884952 · DOI
- Talari K, Goyal M. Retrospective studies - utility and caveats. J R Coll Physicians Edinb. 2020. PMID 33469615 · DOI
- Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005. PMID 15961549 · DOI
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-29.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.